2020/03/17

Question 1

How many patients have been diagnosed over the last 6 months with epithelial ovarian, fallopian tube or primary peritoneal cancer?

If none, do you refer ovarian cancer patients to another trust, if so which one?

A)     22

Question 2

Of the ovarian patients, how many have been tested for BRCA mutation?

If unknown please state unknown and move to Question 4

Question 3

Of the ovarian patient BRCA mutation tests how many tested positive?

Question 4

Of the ovarian patients diagnosed over the last 6 months, how many have been treated with the below:

Paclitaxel in combination with a platinum-based compound

Platinum-based therapy alone (cisplatin or carboplatin)

Bevacizumab in combination with paclitaxel and carboplatin

Olaparib

Niraparib

Rucaparib

Pegylated liposomal doxorubicin hydrochloride (PLDH) as monotherapy or in combination with a platinum-based compound 

Question 5

Of those who were positive for a BRCA mutation, how many received Olaparib for 1st line maintenance?

Question 6

Of those who were positive for a BRCA mutation, how many received Bevacizumab in combination with paclitaxel and carboplatin for 1st line maintenance?

A)      The Trust has recently moved to a new Oncology e-prescribing system and the specific information requested is currently not able to be extracted from it via the reporting functionality.  We are therefore not able to provide this information.